Company profile
Radiko Holdings Corp
OTC: GEATF · Healthcare · Medical - Pharmaceuticals
PublicHQ Los Angeles, WAReports USD
#703 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 31
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), 3-yr revenue growth · ↓ growth stability, market scale
Methodology →Revenue TTM
$3.2M
Rev growth YoY (TTM)
-30.5%
Net income (FY)
-$10.6M
Employees
22
as of 2026-08-30
Market cap
$4.5k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$5.2M$5.2M2019
Net income-$10.6M-$10.6M2019
Operating income-$10.5M-$10.5M2019
Total assets$2.7M$2.7M2019
Liabilities$4.7M$4.7M2019
Equity-$2.7M-$2.7M2019
Revenue trend
FY2012 – FY2019 · USD
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Radiko Holdings Corp’s revenue?
Radiko Holdings Corp booked $5.2M in FY2019 revenue, growing 5022% year over year — faster than 99% of Healthcare companies we track, at a -205.5% net margin.
Peers · Healthcare
Plus Therapeutics, Inc.30DPlus Therapeutics, Inc.38DZeo ScientifiX, Inc.43DPetros Pharmaceuticals, Inc.47DRegenerative Medical Technology Group Inc.36DWellbeing Digital Sciences Inc.——Key facts
CEOPierluigi Paracchi
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersLos Angeles, WA
ExchangeOTC: GEATF
Employees22
IPO date2017-11-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.